Skip to main content
Top
Published in: International Journal of Hematology 2/2008

01-09-2008 | Original Article

A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China

Authors: Sherilyn A. Gross, Xiongzeng Zhu, Liming Bao, John Ryder, Anh Le, Yan Chen, Xiao Qin Wang, Richard D. Irons

Published in: International Journal of Hematology | Issue 2/2008

Login to get access

Abstract

The frequency of subtypes of lymphoid neoplasms was determined in a prospective series of 831 patients presenting at 29 Shanghai hospitals over a 4-year period. Diagnosis and classification was established in a single laboratory according to the 2001 WHO classification system. The frequency of non-Hodgkin lymphoma was 87.6% (n = 728) and Hodgkin lymphoma was 12.4% (n = 103). The most prevalent NHL subtypes diagnosed using WHO criteria were diffuse large B cell lymphoma (DLBCL), precursor B lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Although a low incidence has been reported in some Asian populations, CLL/SLL was commonly encountered, indicating that chronic lymphoid neoplasms are not rare in Shanghai. Consistent with previous reports, our findings indicate a decrease in the frequency of follicular lymphoma and an increase in T cell neoplasms compared to the West. Precursor T lymphoblastic leukemia/lymphoma, anaplastic large T cell lymphoma, aggressive NK cell leukemia, angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma were prominent subtypes of T cell NHL.
Literature
1.
go back to reference Aisenberg AC. Understanding non-Hodgkin’s lymphoma. Sci Med. 1997;4:28–37. Aisenberg AC. Understanding non-Hodgkin’s lymphoma. Sci Med. 1997;4:28–37.
2.
go back to reference Jaffe E, Harris N, Stein H, Vardiman J. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. Jaffe E, Harris N, Stein H, Vardiman J. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
3.
go back to reference Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–92.PubMed Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–92.PubMed
4.
go back to reference Harrington DS, Ye Y, Weisenburger DD, et al. Malignant Lymphoma in Nebraska and Guangzhou, China. Hum Pathol. 1987;18:924–8.CrossRefPubMed Harrington DS, Ye Y, Weisenburger DD, et al. Malignant Lymphoma in Nebraska and Guangzhou, China. Hum Pathol. 1987;18:924–8.CrossRefPubMed
5.
go back to reference Ohshima K, Suzumiya J, Sato K, Kanda M, Haraoka S, Kikuchi M. B-cell lymphoma of 708 cases in Japan: incidence rates and clinical prognosis according to the REAL classification. Cancer Lett. 1999;135:73–81.CrossRefPubMed Ohshima K, Suzumiya J, Sato K, Kanda M, Haraoka S, Kikuchi M. B-cell lymphoma of 708 cases in Japan: incidence rates and clinical prognosis according to the REAL classification. Cancer Lett. 1999;135:73–81.CrossRefPubMed
6.
go back to reference Ko Y-H, Kim C-W, Park C-S, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Cancer. 1998;83:806–11.CrossRefPubMed Ko Y-H, Kim C-W, Park C-S, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Cancer. 1998;83:806–11.CrossRefPubMed
7.
go back to reference Intragumtornchai T, Wannakrairoj P, Chaimongkol B, et al. Non-Hodgkin’s lymphomas in Thailand: a retrospective pathologic and clinical analysis of 1,391 cases. Cancer. 1996;78:1813–9.CrossRefPubMed Intragumtornchai T, Wannakrairoj P, Chaimongkol B, et al. Non-Hodgkin’s lymphomas in Thailand: a retrospective pathologic and clinical analysis of 1,391 cases. Cancer. 1996;78:1813–9.CrossRefPubMed
8.
go back to reference Ho FC, Todd D, Loke SL, Ng RP, Khoo RK. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period. Int J Cancer. 1984;34:143–8.CrossRefPubMed Ho FC, Todd D, Loke SL, Ng RP, Khoo RK. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period. Int J Cancer. 1984;34:143–8.CrossRefPubMed
9.
go back to reference Kwong YL, Wong KF, Chan LC, et al. The spectrum of chronic lymphoproliferative disorders in Chinese people. An analysis of 64 cases. Cancer. 1994;74:174–81.CrossRefPubMed Kwong YL, Wong KF, Chan LC, et al. The spectrum of chronic lymphoproliferative disorders in Chinese people. An analysis of 64 cases. Cancer. 1994;74:174–81.CrossRefPubMed
10.
go back to reference World Health Organization. World cancer report. Lyon: IARC Press; 2003. World Health Organization. World cancer report. Lyon: IARC Press; 2003.
11.
go back to reference Alexander DD, Mink PJ, Adami HO, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer. 2007;120:1–39.CrossRefPubMed Alexander DD, Mink PJ, Adami HO, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer. 2007;120:1–39.CrossRefPubMed
12.
go back to reference Cucuianu A, Patiu M, Duma M, et al. Hepatitis B and C virus infection in Romanian non-Hodgkin’s lymphoma patients. Br J Haematol. 1999;107:353–6.CrossRefPubMed Cucuianu A, Patiu M, Duma M, et al. Hepatitis B and C virus infection in Romanian non-Hodgkin’s lymphoma patients. Br J Haematol. 1999;107:353–6.CrossRefPubMed
13.
go back to reference Wang F, Xu RH, Han B, et al. High incidence of Hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer. 2007;109:1360–4.CrossRefPubMed Wang F, Xu RH, Han B, et al. High incidence of Hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer. 2007;109:1360–4.CrossRefPubMed
14.
go back to reference Wang J, Young L, Win W, Taylor CR. Distribution and Zap-70 expression of WHO lymphoma categories in Shanxi, China: a review of 447 cases using a tissue microarray technique. Appl Immunohistochem Mol Morphol. 2005;13:323–32.CrossRefPubMed Wang J, Young L, Win W, Taylor CR. Distribution and Zap-70 expression of WHO lymphoma categories in Shanxi, China: a review of 447 cases using a tissue microarray technique. Appl Immunohistochem Mol Morphol. 2005;13:323–32.CrossRefPubMed
15.
go back to reference Mitelman F. An international system for human cytogenetic nomenclature: recommendations of the International Standing Committee on Human Cytogenetic Nomenclature, Memphis, TN, October 1994. New York: Karger; 1995. Mitelman F. An international system for human cytogenetic nomenclature: recommendations of the International Standing Committee on Human Cytogenetic Nomenclature, Memphis, TN, October 1994. New York: Karger; 1995.
16.
go back to reference Xiao C, Su ZL, Wu QL, et al. Clinical and pathological reassessment of 493 cases of non-Hodgkin’s lymphomas according to current WHO classification of lymphoid neoplasms. (Chinese). Chinese Journal of Pathology. 2005;34:22–7.PubMed Xiao C, Su ZL, Wu QL, et al. Clinical and pathological reassessment of 493 cases of non-Hodgkin’s lymphomas according to current WHO classification of lymphoid neoplasms. (Chinese). Chinese Journal of Pathology. 2005;34:22–7.PubMed
17.
go back to reference Shih LY, Liang DC. Non-Hodgkin’s lymphomas in Asia. Hematol Oncol Clin North Am. 1991;5:983–1001.PubMed Shih LY, Liang DC. Non-Hodgkin’s lymphomas in Asia. Hematol Oncol Clin North Am. 1991;5:983–1001.PubMed
18.
go back to reference Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s lymphoma classification project. J Clin Oncol. 1998;16:2780–95.CrossRefPubMed Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s lymphoma classification project. J Clin Oncol. 1998;16:2780–95.CrossRefPubMed
19.
go back to reference Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 1995;85:1151–68.PubMed Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 1995;85:1151–68.PubMed
20.
go back to reference Gokbuget N, Hoelzer D. Recent approaches in acute lymphoblastic leukemia in adults. Rev Clin Exp Hematol. 2002;6:114–41.CrossRefPubMed Gokbuget N, Hoelzer D. Recent approaches in acute lymphoblastic leukemia in adults. Rev Clin Exp Hematol. 2002;6:114–41.CrossRefPubMed
21.
go back to reference Ohshima K, Suzumiya J, Kikuchi M. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka. Pathol Int. 2002;52:1–12.CrossRefPubMed Ohshima K, Suzumiya J, Kikuchi M. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka. Pathol Int. 2002;52:1–12.CrossRefPubMed
22.
go back to reference Chuang SS, Lin CN, Li CY. Malignant lymphoma in Southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer. 2000;89:1586–92.CrossRefPubMed Chuang SS, Lin CN, Li CY. Malignant lymphoma in Southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer. 2000;89:1586–92.CrossRefPubMed
23.
go back to reference Chen CY, Yao M, Tang JL, et al. Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin’s lymphoma in Taiwan: with special reference to T-cell lymphoma. Ann Oncol. 2004;15:1091–6.CrossRefPubMed Chen CY, Yao M, Tang JL, et al. Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin’s lymphoma in Taiwan: with special reference to T-cell lymphoma. Ann Oncol. 2004;15:1091–6.CrossRefPubMed
24.
go back to reference Ryder J, Wang X, Bao L, Gross S, Hua F, Irons R. Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature. Int J Hematol. 2007;85:18–25.CrossRefPubMed Ryder J, Wang X, Bao L, Gross S, Hua F, Irons R. Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature. Int J Hematol. 2007;85:18–25.CrossRefPubMed
Metadata
Title
A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China
Authors
Sherilyn A. Gross
Xiongzeng Zhu
Liming Bao
John Ryder
Anh Le
Yan Chen
Xiao Qin Wang
Richard D. Irons
Publication date
01-09-2008
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2008
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-008-0132-1

Other articles of this Issue 2/2008

International Journal of Hematology 2/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine